Research progress in population pharmacokinetics of rituximab / 中国临床药理学与治疗学
Chinese Journal of Clinical Pharmacology and Therapeutics
; (12): 468-474, 2023.
Article
em Zh
| WPRIM
| ID: wpr-1014654
Biblioteca responsável:
WPRO
ABSTRACT
Rituximab, a chimeric human-mouse monoclonal antibody, has been used as a first-line treatment for CD20
Texto completo:
1
Base de dados:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Clinical Pharmacology and Therapeutics
Ano de publicação:
2023
Tipo de documento:
Article